This inventor holds 1 USPTO granted patent and 3 published patent applications. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Years Active: 2024
Title: Aidan Riley: Innovator in Therapeutic Binding Molecules
Introduction
Aidan Riley is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of therapeutic binding molecules, particularly in relation to the chemokine receptor CCR9. His work focuses on addressing CCR9-mediated diseases, such as inflammatory bowel disease (IBD).
Latest Patents
Aidan Riley holds 1 patent for his invention titled "Therapeutic binding molecules." This invention pertains to binding molecules, including antibodies, that specifically target the CCR9 receptor. The implications of this invention are profound, as it offers potential treatment options for various conditions associated with CCR9.
Career Highlights
Throughout his career, Aidan has demonstrated a commitment to advancing medical science through innovative research. His work has not only contributed to the understanding of CCR9 but also paved the way for new therapeutic strategies.
Collaborations
Aidan has collaborated with esteemed colleagues, including Josquin Nys and Albert George Thom. These partnerships have enhanced the research and development of his inventions, fostering a collaborative environment for innovation.
Conclusion
Aidan Riley's contributions to the field of therapeutic binding molecules highlight his role as a key innovator in medical research. His work continues to inspire advancements in the treatment of complex diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile